Ophthalmology News

• New Health Cybersecurity Rule: What Docs Should Know A proposed federal rule would require hospitals and physicians’ groups to beef up health cybersecurity measures to protect patient privacy and prevent ransomware attacks. Some changes could be expensive, experts said.
  Medscape Medical News, January 10, 2025
• Inventory System Supplier Settles Anti-Kickback Claim A specialty pharmacy company agreed to a $1.67 million settlement that it gave inventory management systems to retina specialty practices for free in exchange for drug orders.
  Medscape Medical News, January 09, 2025
• New Therapy Brings Hope for Dry AMD Vision Loss The FDA has approved a first-of-its-kind treatment for dry age–related macular degeneration, a leading cause of blindness in adults over 55.
  WebMD Health News, January 08, 2025
• Early Patching Benefits Kids Born With Cataract in One Eye Consistent daily patching in the first year after surgery improved visual acuity in children with a congenital cataract in one eye, according to a post hoc analysis of the Infant Aphakia Treatment Study.
  Medscape Medical News, January 08, 2025
• Dry January: Should Doctors Make It Year-Round? Have sobering studies on alcohol caused physicians to drink less themselves or changed the way doctors counsel patients on booze? The answer is complicated.
  Medscape Medical News, January 07, 2025
• Sjögren Subtypes Have Distinct Pathophysiologic Profiles Three distinct subtypes of Sjögren disease showed different cytokine profiles and interferon signatures.
  Medscape Medical News, January 07, 2025
• Osteoporosis Medications Linked to Acute Angle Closure Risk Patients with osteoporosis who took bisphosphonates, especially risedronate, were at a higher risk of developing acute angle closure, a recent study found.
  Medscape Medical News, January 06, 2025
• Combining Retinal Scanning and Liver Screening in T2D A novel screening approach combining liver examination with retina scanning showed high acceptance among patients with type 2 diabetes, even though false-positive results were common.
  Medscape Medical News, December 23, 2024
• ASCO 2024 How Cell Therapies Help Fight Solid Tumors The director of solid tumor therapy at Stanford Medicine describes how cellular therapies are transforming cancer care.
  Medscape Medical News, December 23, 2024
• US Suffers First Severe Human Case of Bird Flu; California Declares Emergency The U.S. reported its first severe human case of bird flu on Wednesday in a Louisiana resident who is hospitalized in critical condition after suspected contact with an...
  Reuters Health Information, December 18, 2024
• Study Finds Association Between Statins and Glaucoma People with high cholesterol taking statins have a higher prevalence of glaucoma than those with elevated cholesterol but not taking the drug, a study found.
  Medscape Medical News, December 18, 2024
• Novo's Ozempic Faces Scrutiny Over Potential Link to Rare Eye Disease Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two Danish studies linking Novo Nordisk's popular...
  Reuters Health Information, December 16, 2024
• Viridian Shares Soar After Latest Trial Success for Thyroid Eye Disease Drug Viridian Therapeutics' experimental treatment for chronic thyroid eye disease (TED) significantly reduced symptoms such as double vision and eye bulging in a late-stage...
  Reuters Health Information, December 16, 2024
• Oral Doxycycline Shows Promise in Ocular Syphilis Care Oral doxycycline may be as effective as IV penicillin in treating ocular syphilis for some patients with the condition, a new study found.
  Medscape Medical News, December 13, 2024
• Diabetes Drugs and Eye Disease: These Protect, These Don’t Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular edema, a large-scale analysis of electronic medical records revealed.
  Medscape Medical News, December 12, 2024
• SABCS 2024 Olaparib Protects Patients From High-Risk Cancer Recurrences The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first patient in the phase 3 OlympiA trial was enrolled.
  Medscape Medical News, December 12, 2024
• Eye Toxicities Are a Growing Concern With Certain ADCs Some antibody-drug conjugates may cause such significant ocular toxicity that patients have vision damage or have to stop treatment, yet many oncologists are unaware of the risks, experts warned.
  Medscape Medical News, December 11, 2024
• Empagliflozin May Slow Diabetic Retinopathy Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 diabetes and a history of nonproliferative diabetic retinopathy, a US-based cohort study found.
  Medscape Medical News, December 06, 2024
• Meta-analysis Probes Rare Potential Vision Risk of GLP-1s A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be detected in patients with type 2 diabetes and/or obesity.
  Medscape Medical News, December 06, 2024
• Higher Risk for Herpes Zoster Complications With IBD Patients with IBD were more likely to have complications of herpes zoster than those without IBD, highlighting the importance of vaccination in this population.
  Medscape Medical News, December 06, 2024